CPIG
FMTX

Chicago Partners Investment Group’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Chicago Partners Investment Group’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,292
Closed -$85K – 633
2022
Q2 		$85K Buy
10,292
+56
+0.5% +$393 0.01% 574
2022
Q1 		$61K Sell
10,236
-1,344
-12% -$14.3K ﹤0.01% 548
2021
Q4 		$125K Sell
11,580
-2,359
-17% -$40.8K 0.01% 540
2021
Q3 		$256K Sell
13,939
-243
-2% -$5.75K 0.02% 478
2021
Q2 		$337K Sell
14,182
-743
-5% -$20K 0.03% 403
2021
Q1 		$410K Sell
14,925
-1,445
-9% -$52.1K 0.03% 334
2020
Q4 		$638K Buy
16,370
+10,098
+161% +$440K 0.06% 237
2020
Q3 		$282K Buy
+6,272
New +$253K 0.03% 328

Other funds holding FMTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Chicago Partners Investment Group's FMTX Position: Q3 2022 in Review

Chicago Partners Investment Group sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q3 2022, closing a stake of 10,292 shares — an estimated $85K sold.

Chicago Partners Investment Group first reported a position in FMTX in Q3 2020 and held it in 8 quarters. The position peaked at $638K in Q4 2020. 139 funds tracked by Wall St. Rank hold FMTX as of Q3 2022.

  • Chicago Partners Investment Group reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Chicago Partners Investment Group sold 10,292 Forma Therapeutics Holdings, Inc. Common Stock shares in Q3 2022, an estimated $85K.
  • Chicago Partners Investment Group first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2020 and held it in 8 quarters.
  • Chicago Partners Investment Group's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $638K in Q4 2020.
  • 139 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q3 2022.

Based on Chicago Partners Investment Group's 13F filing for Q3 2022, filed 9 Nov 2022.